SCHEMBL4630848

SCHEMBL4630848

CCC(NC(=O)Cc1ccc(SCc2ccccc2C(=O)O)cc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.60
PPARA Q07869 12/20 0.60
CNR2 P34972 2/20 0.49
UTS2R Q9UKP6 3/20 0.46
KCNA5 P22460 1/20 0.44
MAPT P10636 1/20 0.43
GPR139 Q6DWJ6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630851 0.76 PPARG (0.63) PPARGPPARACNR2
SCHEMBL977475 0.75 PPARG (1.00) PPARGPPARA
SCHEMBL978747 0.75 PPARG (1.00) PPARGPPARA
SCHEMBL1365900 0.74 ALDH1A1 (0.56) KCNA5
Tert-Butylamine SCHEMBL5308906 0.73 PPARG (0.59) PPARGPPARA
SCHEMBL5312651 0.71 PPARG (0.61) PPARGPPARAMAPT
SCHEMBL979749 0.70 PPARG (1.00) PPARGPPARA
SCHEMBL979751 0.69 PPARG (0.61) PPARGPPARA
SCHEMBL11864635 0.69 PPARG (0.76) PPARGPPARA
SCHEMBL4630714 0.69 PPARG (0.53) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517883-B8 ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE ASTRAZENECA AB (SE) 2008-05-21 EP claimed
EP-1517883-B1 ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE ASTRAZENECA AB (SE) 2008-02-13 EP claimed
EP-1517883-A1 ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE AstraZeneca AB (SE) 2005-03-30 EP claimed
WO-2004000790-A1 ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE ASTRAZENECA AB (SE) 2003-12-31 WO claimed